Cargando…
Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer
Introduction: Loco regional persistence or recurrence of differentiated thyroid cancer (DTC) is frequent despite initial thyroidectomy and radioactive iodine therapy (RAI). The aim of this study was to analyze the impact of a complementary adjuvant RAI (Ad-RAI) on disease recurrence following re-ope...
Autores principales: | Bouvet, Clément, Barres, Bertrand, Kwiatkowski, Fabrice, Batisse-Lignier, Marie, Chafai El Alaoui, Meryem, Kauffmann, Philippe, Cachin, Florent, Tauveron, Igor, Kelly, Antony, Maqdasy, Salwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776597/ https://www.ncbi.nlm.nih.gov/pubmed/31611847 http://dx.doi.org/10.3389/fendo.2019.00671 |
Ejemplares similares
-
Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients
por: Kelly, Antony, et al.
Publicado: (2019) -
Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature
por: Maqdasy, Salwan, et al.
Publicado: (2015) -
Idiopathic central precocious puberty in a Klinefelter patient: highlights on gonadotropin levels and pathophysiology
por: Maqdasy, Salwan, et al.
Publicado: (2020) -
Time course of Graves’ orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer
por: Louvet, Camille, et al.
Publicado: (2016) -
Assessment of oro-dental manifestations in a series of acromegalic patients, the AcroDent study
por: Roumeau, Sylvain, et al.
Publicado: (2020)